Current and historical daily PE Ratio for Biotage AB (
) from 2010 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biotage AB stock (BITGF) PE ratio as of Apr 26 2024 is 52.79.
More Details
Biotage AB (BITGF) PE Ratio (TTM) Chart
Biotage AB (BITGF) PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Total 1214
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Biotage AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-26 | 49.1 | 2024-02-22 | 37.5 |
| 2024-04-25 | 49.1 | 2024-02-21 | 37.5 |
| 2024-04-24 | 56.6 | 2024-02-20 | 37.5 |
| 2024-04-23 | 56.6 | 2024-02-16 | 37.5 |
| 2024-04-22 | 56.6 | 2024-02-15 | 37.5 |
| 2024-04-19 | 56.6 | 2024-02-14 | 37.5 |
| 2024-04-18 | 56.6 | 2024-02-13 | 37.5 |
| 2024-04-17 | 56.6 | 2024-02-12 | 37.5 |
| 2024-04-16 | 56.6 | 2024-02-09 | 37.5 |
| 2024-04-15 | 56.6 | 2024-02-08 | 37.5 |
| 2024-04-12 | 56.6 | 2024-02-07 | 37.5 |
| 2024-04-11 | 56.6 | 2024-02-06 | 37.5 |
| 2024-04-10 | 56.6 | 2024-02-05 | 37.5 |
| 2024-04-09 | 56.6 | 2024-02-02 | 37.5 |
| 2024-04-08 | 56.6 | 2024-02-01 | 37.5 |
| 2024-04-05 | 56.6 | 2024-01-31 | 37.5 |
| 2024-04-04 | 56.6 | 2024-01-30 | 37.5 |
| 2024-04-03 | 56.6 | 2024-01-29 | 37.5 |
| 2024-04-02 | 56.6 | 2024-01-26 | 37.5 |
| 2024-04-01 | 56.6 | 2024-01-25 | 37.5 |
| 2024-03-28 | 56.6 | 2024-01-24 | 37.5 |
| 2024-03-27 | 52.7 | 2024-01-23 | 37.5 |
| 2024-03-26 | 52.7 | 2024-01-22 | 37.5 |
| 2024-03-25 | 52.7 | 2024-01-19 | 37.5 |
| 2024-03-22 | 37.5 | 2024-01-18 | 37.5 |
| 2024-03-21 | 37.5 | 2024-01-17 | 37.5 |
| 2024-03-20 | 37.5 | 2024-01-16 | 37.5 |
| 2024-03-19 | 37.5 | 2024-01-12 | 37.5 |
| 2024-03-18 | 37.5 | 2024-01-11 | 37.5 |
| 2024-03-15 | 37.5 | 2024-01-10 | 37.5 |
| 2024-03-14 | 37.5 | 2024-01-09 | 37.5 |
| 2024-03-13 | 37.5 | 2024-01-08 | 37.5 |
| 2024-03-12 | 37.5 | 2024-01-05 | 37.5 |
| 2024-03-11 | 37.5 | 2024-01-04 | 37.5 |
| 2024-03-08 | 37.5 | 2024-01-03 | 37.5 |
| 2024-03-07 | 37.5 | 2024-01-02 | 37.5 |
| 2024-03-06 | 37.5 | 2023-12-29 | 37.5 |
| 2024-03-05 | 37.5 | 2023-12-28 | 37.5 |
| 2024-03-04 | 37.5 | 2023-12-27 | 46.5 |
| 2024-03-01 | 37.5 | 2023-12-26 | 46.5 |
| 2024-02-29 | 37.5 | 2023-12-22 | 46.5 |
| 2024-02-28 | 37.5 | 2023-12-21 | 46.5 |
| 2024-02-27 | 37.5 | 2023-12-20 | 46.5 |
| 2024-02-26 | 37.5 | 2023-12-19 | 46.5 |
| 2024-02-23 | 37.5 | 2023-12-18 | 46.5 |
Biotage AB (BITGF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Biotage AB
ISIN : SE0000454746
Share Class Description:
BITGF: Ordinary SharesCompare
Compare
Traded in other countries / regions
BIOT.Sweden0GRP.UKPQX1.GermanyBITGF.USA IPO Date
2010-02-18Description
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers